Trades on 3 secondary markets

Egenesis

eGenesis is a biotechnology company working at the intersection of genome engineering and transplantation to make organ transplants accessible to all. Using a multiplex CRISPR gene-editing and genome-engineering platform, eGenesis engineers porcine (pig) donor organs that are immunologically and mol

emerging 15.0 / 100 0 APIs View provider profile →

Company Biotech Xenotransplantation Gene Editing Genome Engineering Organ Transplantation

Egenesis is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, EquityZen.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.